Oruka Therapeutics (ORKA) Operating Income Growth (1y) (2011 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,386.07% |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -58.24% |
| Mar 31, 2024 | -38.20% |
| Dec 31, 2023 | -2.71% |
| Sep 30, 2023 | 24.10% |
| Jun 30, 2023 | 38.71% |
| Mar 31, 2023 | 45.19% |
| Dec 31, 2022 | 72.75% |
| Sep 30, 2022 | 45.89% |
| Jun 30, 2022 | 33.45% |
| Mar 31, 2022 | 20.11% |
| Dec 31, 2021 | -10.81% |
| Sep 30, 2021 | -136.98% |
| Jun 30, 2021 | -269.24% |
| Mar 31, 2021 | -206.12% |
| Dec 31, 2020 | -301.10% |
| Sep 30, 2020 | -59.58% |
| Jun 30, 2020 | 13.13% |
| Mar 31, 2020 | 24.76% |
| Dec 31, 2019 | -125.95% |
| Sep 30, 2019 | 24.97% |
| Jun 30, 2019 | 30.06% |
| Mar 31, 2019 | 35.77% |
| Dec 31, 2018 | -39.41% |
| Sep 30, 2018 | 62.86% |
| Jun 30, 2018 | 61.22% |
| Mar 31, 2018 | 36.70% |
| Dec 31, 2017 | 289.40% |
| Sep 30, 2017 | 5.03% |
| Jun 30, 2017 | -41.06% |
| Mar 31, 2017 | -19.44% |
| Dec 31, 2016 | -35.18% |
| Sep 30, 2016 | -67.27% |
| Jun 30, 2016 | -44.94% |
| Mar 31, 2016 | -33.67% |
| Dec 31, 2015 | -21.55% |
| Sep 30, 2015 | -23.28% |
| Jun 30, 2015 | -13.01% |
| Mar 31, 2015 | -14.81% |
| Dec 31, 2014 | 11.37% |
| Sep 30, 2014 | -32.46% |
| Jun 30, 2014 | -100.83% |
| Mar 31, 2014 | -123.36% |
| Dec 31, 2013 | -249.75% |
| Sep 30, 2013 | -85.88% |
| Jun 30, 2013 | -4.63% |
| Mar 31, 2013 | 23.90% |
| Dec 31, 2012 | 220.44% |
| Sep 30, 2012 | 49.04% |
| Jun 30, 2012 | 32.81% |
| Mar 31, 2012 | 36.15% |
| Dec 31, 2011 | 30.53% |
| Sep 30, 2011 | 13.53% |
| Jun 30, 2011 | 24.90% |